Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
Background New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers …
which include stages for cognitively normal individuals with abnormal amyloid markers …
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
SJ Vos, C Xiong, PJ Visser… - The Lancet …, 2013 - pubmed.ncbi.nlm.nih.gov
Background New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers …
which include stages for cognitively normal individuals with abnormal amyloid markers …
Preclinical Alzheimer's disease and its outcome: A longitudinal cohort study.
SJB Vos, C Xiong, PJ Visser, MS Jasielec… - The Lancet …, 2013 - psycnet.apa.org
Background: New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers …
which include stages for cognitively normal individuals with abnormal amyloid markers …
[HTML][HTML] Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
SJB Vos, C Xiong, PJ Visser, MS Jasielec… - Lancet …, 2013 - ncbi.nlm.nih.gov
Background New research criteria for preclinical Alzheimer's disease (AD) have been
proposed by the National Institute on Aging and Alzheimer's Association. They include …
proposed by the National Institute on Aging and Alzheimer's Association. They include …
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
SJB Vos, C Xiong, PJ Visser, MS Jasielec… - The Lancet …, 2013 - thelancet.com
Background New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers …
which include stages for cognitively normal individuals with abnormal amyloid markers …
Preclinical Alzheimer's disease and its outcome: A longitudinal cohort study
SJB Vos, C Xiong, PJ Visser, MS Jasielec… - The Lancet …, 2013 - profiles.wustl.edu
Background: New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers …
which include stages for cognitively normal individuals with abnormal amyloid markers …
[PDF][PDF] Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
SJB Vos, C Xiong, PJ Visser, MS Jasielec… - Lancet …, 2013 - researchgate.net
Background New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers …
which include stages for cognitively normal individuals with abnormal amyloid markers …
[引用][C] Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
SJB Vos, C Xiong, PJ Visser, MS Jasielec… - The Lancet …, 2013 - cir.nii.ac.jp
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
SJB Vos, C Xiong, PJ Visser, MS Jasielec… - The Lancet …, 2013 - Elsevier
Background New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers …
which include stages for cognitively normal individuals with abnormal amyloid markers …
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.
SJ Vos, C Xiong, PJ Visser, MS Jasielec… - The Lancet …, 2013 - europepmc.org
Background New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers …
which include stages for cognitively normal individuals with abnormal amyloid markers …